Stamford Therapeutics Consortium

Lipid Storage Disorders

Lipid storage disorders, or lipidoses, are a category of genetic metabolic disorders characterized by harmful levels of excessive lipids that may accumulate in the cells and tissues. The body does not produce enough enzymes to metabolize the fats, causing cellular and tissue damage over time. Permanent damage can occur in the brain, peripheral nervous system, liver, spleen and bone marrow.

Related disorders may include:

• Fabry disease
• Farber disease
• Fucosidosis
• Gaucher disease
• GM1 Gangliosidoses
• GM2 Gangliosidoses
• Krabbe Disease
• Metachromatic Leukodystrophy (MLD)
• Multiple Sulfatase Deficiency
• Niemann-Pick disease
• Schindler Disease
• Wolman Disease


Sorry, we are currently not conducting a clinical trial for this condition. Please check back because we frequently add new studies. Feel free to contact Judy Dalgin, our Site Manager, for more information about upcoming trials.

Clinical Trial Contact FormYou may also fill out the Clinical Trial Contact Form and we will contact you when a new trial is added for any of the conditions you have indicated.

Judy Dalgin (Site Manager)
email: jdalgin@stctrials.com
telephone: 203-325-8529

Stamford Therapeutics Consortium

Copyright © • Stamford Therapeutics Consortium • All Rights Reserved
Website Designed & Maintained By SkyeLine Studio, LLC.